Kyoei Tanker Co., Ltd.(JP:9130)
¥1,403.00+23.00 (+1.67%)
JP:9130
Kyoei Tanker Co., Ltd. stock drug pipeline
¥1,403.00
At close:+23.00 (+1.67%)
Want to see JP:9130 full AI Analyst Report?
Kyoei Tanker Co., Ltd. (9130) Drug Pipeline
0 Followers
This company reports no clinical trials.
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kyoei Tanker Co., Ltd. (JP:9130) have in its pipeline
Kyoei Tanker Co., Ltd. JP:9130 does not currently report any drugs in clinical development.
